Nagayama, Manabu
Funayama, Yohei
Taniguchi, Osamu
Hatano, Kaoru
Oguro, Kunihiko
Owada, Jun
Sakamoto, Hirotsugu
Yano, Tomonori
Longman, Randy Scott
Yamamoto, Hironori https://orcid.org/0000-0002-3601-1153
Article History
Received: 8 April 2024
Accepted: 14 July 2024
First Online: 31 July 2024
Declarations
:
: H. Yamamoto has received honoraria, grants, and royalties from the Fujifilm Corporation. He has also received honoraria from Takeda Pharmaceutical Company, Janssen Pharmaceutical, Mitsubishi Tanabe Pharma Corporation, and AbbVie Inc. R. Longman is a board member of Pfizer, BMS, and CJ Bioscience and received a research grant from Boehringer Ingelheim. T. Yano received honoraria from Otsuka Pharmaceutical factory and Takeda Pharmaceutical Company. H. Sakamoto received a research grant from Fujifilm Corporation and an endowed chair from FUJIFILM Medical Co. Ltd. The other authors disclose no conflicts.
: All the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008(5).
: Informed consent was obtained from all the patients to be included in the study.